1 |
TUBB3
| 10件: Phagosome Phagosome 💬, Gap junction 💬, Alzheimer disease 💬, Parkinson disease 💬, Amyotrophic lateral sclerosis 💬, Huntington disease 💬, Prion disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Pathogenic Escherichia coli infection 💬, Salmonella infection 💬 | D09587
D09587
|
Brentuximab vedotin
| 2件: 49 49, 51 |
2 |
TUBB4A
| 10件: Phagosome Phagosome 💬, Gap junction 💬, Alzheimer disease 💬, Parkinson disease 💬, Amyotrophic lateral sclerosis 💬, Huntington disease 💬, Prion disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Pathogenic Escherichia coli infection 💬, Salmonella infection 💬 | D09587
D09587
|
Brentuximab vedotin
| 2件: 49 49, 51 |
3 |
TUBB4B
| 10件: Phagosome Phagosome 💬, Gap junction 💬, Alzheimer disease 💬, Parkinson disease 💬, Amyotrophic lateral sclerosis 💬, Huntington disease 💬, Prion disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Pathogenic Escherichia coli infection 💬, Salmonella infection 💬 | D09587
D09587
|
Brentuximab vedotin
| 2件: 49 49, 51 |
4 |
TNFSF13B
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬, NF-kappa B signaling pathway 💬, Intestinal immune network for IgA production 💬, Rheumatoid arthritis 💬 | D03068
D03068
|
Belimumab
| 12件: 11 11, 13, 43, 44, 46, 49, 51, 53, 66, 222, 296, 300 |
5 |
CNR2
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D11312
D11312
|
Ajulemic acid
| 2件: 51 51, 299 |
6 |
IL31RA
| 1件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | D11080
D11080
|
Nemolizumab
| 1件: 51 51 |
7 |
CSF3R
| 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬, PI3K-Akt signaling pathway 💬, JAK-STAT signaling pathway 💬, Hematopoietic cell lineage 💬, Pathways in cancer 💬 | D03235
D03235
|
Filgrastim
| 34件: 2 2, 6, 11, 13, 16, 25, 26, 28, 34, 35, 36, 38, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 |
8 |
DHFR
| 5件: One carbon pool by folate One carbon pool by folate 💬, Folate biosynthesis 💬, Metabolic pathways 💬, Biosynthesis of cofactors 💬, Antifolate resistance 💬 | D00142
D00142
|
Methotrexate
| 38件: 11 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 |
9 |
DHFR
| 5件: One carbon pool by folate One carbon pool by folate 💬, Folate biosynthesis 💬, Metabolic pathways 💬, Biosynthesis of cofactors 💬, Antifolate resistance 💬 | D02115
D02115
|
Methotrexate
| 38件: 11 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 |
10 |
DRD2
| 8件: Rap1 signaling pathway Rap1 signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Gap junction 💬, Dopaminergic synapse 💬, Parkinson disease 💬, Cocaine addiction 💬, Alcoholism 💬 | D00702
D00702
|
Buspirone
| 3件: 6 6, 51, 179 |
11 |
DRD2
| 8件: Rap1 signaling pathway Rap1 signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Gap junction 💬, Dopaminergic synapse 💬, Parkinson disease 💬, Cocaine addiction 💬, Alcoholism 💬 | D00726
D00726
|
Metoclopramide
| 1件: 51 51 |
12 |
DRD2
| 8件: Rap1 signaling pathway Rap1 signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Gap junction 💬, Dopaminergic synapse 💬, Parkinson disease 💬, Cocaine addiction 💬, Alcoholism 💬 | D01348
D01348
|
Terguride
| 2件: 51 51, 86 |
13 |
DRD2
| 8件: Rap1 signaling pathway Rap1 signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Gap junction 💬, Dopaminergic synapse 💬, Parkinson disease 💬, Cocaine addiction 💬, Alcoholism 💬 | D01745
D01745
|
Domperidone
| 5件: 6 6, 13, 17, 51, 230 |
14 |
DRD2
| 8件: Rap1 signaling pathway Rap1 signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Gap junction 💬, Dopaminergic synapse 💬, Parkinson disease 💬, Cocaine addiction 💬, Alcoholism 💬 | D02213
D02213
|
Metoclopramide
| 1件: 51 51 |
15 |
DRD2
| 8件: Rap1 signaling pathway Rap1 signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Gap junction 💬, Dopaminergic synapse 💬, Parkinson disease 💬, Cocaine addiction 💬, Alcoholism 💬 | D05008
D05008
|
Metoclopramide
| 1件: 51 51 |
16 |
DRD2
| 8件: Rap1 signaling pathway Rap1 signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Gap junction 💬, Dopaminergic synapse 💬, Parkinson disease 💬, Cocaine addiction 💬, Alcoholism 💬 | D07593
D07593
|
Buspirone
| 3件: 6 6, 51, 179 |
17 |
DRD2
| 8件: Rap1 signaling pathway Rap1 signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Gap junction 💬, Dopaminergic synapse 💬, Parkinson disease 💬, Cocaine addiction 💬, Alcoholism 💬 | D07868
D07868
|
Domperidone
| 5件: 6 6, 13, 17, 51, 230 |
18 |
EDNRA
| 7件: Calcium signaling pathway Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Vascular smooth muscle contraction 💬, Renin secretion 💬, Pathways in cancer 💬 | D01227
D01227
|
Bosentan
| 11件: 13 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 |
19 |
EDNRA
| 7件: Calcium signaling pathway Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Vascular smooth muscle contraction 💬, Renin secretion 💬, Pathways in cancer 💬 | D07077
D07077
|
Ambrisentan
| 7件: 51 51, 84, 85, 86, 88, 210, 211 |
20 |
EDNRA
| 7件: Calcium signaling pathway Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Vascular smooth muscle contraction 💬, Renin secretion 💬, Pathways in cancer 💬 | D07538
D07538
|
Bosentan
| 11件: 13 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 |
21 |
EDNRA
| 7件: Calcium signaling pathway Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Vascular smooth muscle contraction 💬, Renin secretion 💬, Pathways in cancer 💬 | D07741
D07741
|
Zibotentan
| 1件: 51 51 |
22 |
EDNRA
| 7件: Calcium signaling pathway Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Vascular smooth muscle contraction 💬, Renin secretion 💬, Pathways in cancer 💬 | D10135
D10135
|
Macitentan
| 5件: 51 51, 85, 86, 88, 210 |
23 |
EDNRB
| 6件: Calcium signaling pathway Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Melanogenesis 💬, Relaxin signaling pathway 💬, Pathways in cancer 💬 | D01227
D01227
|
Bosentan
| 11件: 13 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 |
24 |
EDNRB
| 6件: Calcium signaling pathway Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Melanogenesis 💬, Relaxin signaling pathway 💬, Pathways in cancer 💬 | D07538
D07538
|
Bosentan
| 11件: 13 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 |
25 |
EDNRB
| 6件: Calcium signaling pathway Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Melanogenesis 💬, Relaxin signaling pathway 💬, Pathways in cancer 💬 | D10135
D10135
|
Macitentan
| 5件: 51 51, 85, 86, 88, 210 |
26 |
EGFR
| 48件: EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance 💬, Endocrine resistance 💬, MAPK signaling pathway 💬, ErbB signaling pathway 💬, Ras signaling pathway 💬, Rap1 signaling pathway 💬, Calcium signaling pathway 💬, HIF-1 signaling pathway 💬, FoxO signaling pathway 💬, Phospholipase D signaling pathway 💬, Endocytosis 💬, PI3K-Akt signaling pathway 💬, Focal adhesion 💬, Adherens junction 💬, Gap junction 💬, JAK-STAT signaling pathway 💬, Regulation of actin cytoskeleton 💬, GnRH signaling pathway 💬, Estrogen signaling pathway 💬, Oxytocin signaling pathway 💬, Relaxin signaling pathway 💬, Parathyroid hormone synthesis, secretion and action 💬, Cushing syndrome 💬, Epithelial cell signaling in Helicobacter pylori infection 💬, Shigellosis 💬, Hepatitis C 💬, Human cytomegalovirus infection 💬, Human papillomavirus infection 💬, Coronavirus disease - COVID-19 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, MicroRNAs in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Chemical carcinogenesis - reactive oxygen species 💬, Colorectal cancer 💬, Pancreatic cancer 💬, Endometrial cancer 💬, Glioma 💬, Prostate cancer 💬, Melanoma 💬, Bladder cancer 💬, Non-small cell lung cancer 💬, Breast cancer 💬, Hepatocellular carcinoma 💬, Gastric cancer 💬, Central carbon metabolism in cancer 💬, Choline metabolism in cancer 💬, PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 | D03455
D03455
|
Cetuximab
| 5件: 34 34, 51, 86, 89, 331 |
27 |
EPHA2
| 5件: MAPK signaling pathway MAPK signaling pathway 💬, Ras signaling pathway 💬, Rap1 signaling pathway 💬, PI3K-Akt signaling pathway 💬, Axon guidance 💬 | D03658
D03658
|
Dasatinib
| 2件: 51 51, 85 |
28 |
EPHA2
| 5件: MAPK signaling pathway MAPK signaling pathway 💬, Ras signaling pathway 💬, Rap1 signaling pathway 💬, PI3K-Akt signaling pathway 💬, Axon guidance 💬 | D06414
D06414
|
Dasatinib
| 2件: 51 51, 85 |
29 |
DHFR2
| 5件: One carbon pool by folate One carbon pool by folate 💬, Folate biosynthesis 💬, Metabolic pathways 💬, Biosynthesis of cofactors 💬, Antifolate resistance 💬 | D00142
D00142
|
Methotrexate
| 38件: 11 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 |
30 |
DHFR2
| 5件: One carbon pool by folate One carbon pool by folate 💬, Folate biosynthesis 💬, Metabolic pathways 💬, Biosynthesis of cofactors 💬, Antifolate resistance 💬 | D02115
D02115
|
Methotrexate
| 38件: 11 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 |
31 |
TUBB
| 10件: Phagosome Phagosome 💬, Gap junction 💬, Alzheimer disease 💬, Parkinson disease 💬, Amyotrophic lateral sclerosis 💬, Huntington disease 💬, Prion disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Pathogenic Escherichia coli infection 💬, Salmonella infection 💬 | D09587
D09587
|
Brentuximab vedotin
| 2件: 49 49, 51 |
32 |
F2
| 8件: Phospholipase D signaling pathway Phospholipase D signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Complement and coagulation cascades 💬, Platelet activation 💬, Regulation of actin cytoskeleton 💬, Pathogenic Escherichia coli infection 💬, Coronavirus disease - COVID-19 💬, Pathways in cancer 💬 | D07144
D07144
|
Dabigatran etexilate
| 1件: 51 51 |
33 |
F2
| 8件: Phospholipase D signaling pathway Phospholipase D signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Complement and coagulation cascades 💬, Platelet activation 💬, Regulation of actin cytoskeleton 💬, Pathogenic Escherichia coli infection 💬, Coronavirus disease - COVID-19 💬, Pathways in cancer 💬 | D09707
D09707
|
Dabigatran
| 4件: 51 51, 85, 91, 124 |
34 |
FGFR1
| 16件: MAPK signaling pathway MAPK signaling pathway 💬, Ras signaling pathway 💬, Rap1 signaling pathway 💬, Calcium signaling pathway 💬, PI3K-Akt signaling pathway 💬, Adherens junction 💬, Signaling pathways regulating pluripotency of stem cells 💬, Thermogenesis 💬, Regulation of actin cytoskeleton 💬, Parathyroid hormone synthesis, secretion and action 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, Prostate cancer 💬, Melanoma 💬, Breast cancer 💬, Central carbon metabolism in cancer 💬 | D10481
D10481
|
Nintedanib
| 5件: 51 51, 85, 89, 227, 228 |
35 |
FGFR3
| 13件: EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance 💬, MAPK signaling pathway 💬, Ras signaling pathway 💬, Rap1 signaling pathway 💬, Calcium signaling pathway 💬, Endocytosis 💬, PI3K-Akt signaling pathway 💬, Signaling pathways regulating pluripotency of stem cells 💬, Regulation of actin cytoskeleton 💬, Pathways in cancer 💬, MicroRNAs in cancer 💬, Bladder cancer 💬, Central carbon metabolism in cancer 💬 | D10481
D10481
|
Nintedanib
| 5件: 51 51, 85, 89, 227, 228 |
36 |
FGFR2
| 13件: EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance 💬, MAPK signaling pathway 💬, Ras signaling pathway 💬, Rap1 signaling pathway 💬, Calcium signaling pathway 💬, Endocytosis 💬, PI3K-Akt signaling pathway 💬, Signaling pathways regulating pluripotency of stem cells 💬, Regulation of actin cytoskeleton 💬, Pathways in cancer 💬, Prostate cancer 💬, Gastric cancer 💬, Central carbon metabolism in cancer 💬 | D10481
D10481
|
Nintedanib
| 5件: 51 51, 85, 89, 227, 228 |
37 |
FLT1
| 9件: MAPK signaling pathway MAPK signaling pathway 💬, Ras signaling pathway 💬, Rap1 signaling pathway 💬, Calcium signaling pathway 💬, HIF-1 signaling pathway 💬, PI3K-Akt signaling pathway 💬, Focal adhesion 💬, Transcriptional misregulation in cancer 💬, Rheumatoid arthritis 💬 | D10481
D10481
|
Nintedanib
| 5件: 51 51, 85, 89, 227, 228 |
38 |
FLT4
| 8件: MAPK signaling pathway MAPK signaling pathway 💬, Ras signaling pathway 💬, Rap1 signaling pathway 💬, Calcium signaling pathway 💬, PI3K-Akt signaling pathway 💬, Focal adhesion 💬, Pathways in cancer 💬, Breast cancer 💬 | D10481
D10481
|
Nintedanib
| 5件: 51 51, 85, 89, 227, 228 |
39 |
IL17RA
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬, IL-17 signaling pathway 💬, Alcoholic liver disease 💬 | D10061
D10061
|
Brodalumab
| 2件: 37 37, 51 |
40 |
MTOR
| 51件: EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance 💬, Endocrine resistance 💬, ErbB signaling pathway 💬, HIF-1 signaling pathway 💬, Phospholipase D signaling pathway 💬, Autophagy - other 💬, Autophagy - animal 💬, mTOR signaling pathway 💬, PI3K-Akt signaling pathway 💬, AMPK signaling pathway 💬, Longevity regulating pathway 💬, Longevity regulating pathway - multiple species 💬, Cellular senescence 💬, Apelin signaling pathway 💬, Neutrophil extracellular trap formation 💬, JAK-STAT signaling pathway 💬, Th17 cell differentiation 💬, Thermogenesis 💬, Insulin signaling pathway 💬, Thyroid hormone signaling pathway 💬, Adipocytokine signaling pathway 💬, Type II diabetes mellitus 💬, Insulin resistance 💬, Growth hormone synthesis, secretion and action 💬, Alzheimer disease 💬, Amyotrophic lateral sclerosis 💬, Huntington disease 💬, Spinocerebellar ataxia 💬, Pathways of neurodegeneration - multiple diseases 💬, Shigellosis 💬, Human cytomegalovirus infection 💬, Human papillomavirus infection 💬, Kaposi sarcoma-associated herpesvirus infection 💬, Herpes simplex virus 1 infection 💬, Human immunodeficiency virus 1 infection 💬, Pathways in cancer 💬, Proteoglycans in cancer 💬, MicroRNAs in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Colorectal cancer 💬, Pancreatic cancer 💬, Glioma 💬, Prostate cancer 💬, Acute myeloid leukemia 💬, Breast cancer 💬, Hepatocellular carcinoma 💬, Gastric cancer 💬, Central carbon metabolism in cancer 💬, Choline metabolism in cancer 💬, PD-L1 expression and PD-1 checkpoint pathway in cancer 💬, Diabetic cardiomyopathy 💬 | D00753
D00753
|
Sirolimus
| 41件: 2 2, 6, 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
41 |
FYN
| 14件: Sphingolipid signaling pathway Sphingolipid signaling pathway 💬, Phospholipase D signaling pathway 💬, Axon guidance 💬, Osteoclast differentiation 💬, Focal adhesion 💬, Adherens junction 💬, Platelet activation 💬, Natural killer cell mediated cytotoxicity 💬, T cell receptor signaling pathway 💬, Fc epsilon RI signaling pathway 💬, Cholinergic synapse 💬, Prion disease 💬, Pathogenic Escherichia coli infection 💬, Viral myocarditis 💬 | D03658
D03658
|
Dasatinib
| 2件: 51 51, 85 |
42 |
FYN
| 14件: Sphingolipid signaling pathway Sphingolipid signaling pathway 💬, Phospholipase D signaling pathway 💬, Axon guidance 💬, Osteoclast differentiation 💬, Focal adhesion 💬, Adherens junction 💬, Platelet activation 💬, Natural killer cell mediated cytotoxicity 💬, T cell receptor signaling pathway 💬, Fc epsilon RI signaling pathway 💬, Cholinergic synapse 💬, Prion disease 💬, Pathogenic Escherichia coli infection 💬, Viral myocarditis 💬 | D06414
D06414
|
Dasatinib
| 2件: 51 51, 85 |
43 |
ABL1
| 11件: ErbB signaling pathway ErbB signaling pathway 💬, Ras signaling pathway 💬, Cell cycle 💬, Axon guidance 💬, Neurotrophin signaling pathway 💬, Pathogenic Escherichia coli infection 💬, Pathways in cancer 💬, MicroRNAs in cancer 💬, Chemical carcinogenesis - reactive oxygen species 💬, Chronic myeloid leukemia 💬, Viral myocarditis 💬 | D01441
D01441
|
Imatinib
| 12件: 13 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 |
44 |
ABL1
| 11件: ErbB signaling pathway ErbB signaling pathway 💬, Ras signaling pathway 💬, Cell cycle 💬, Axon guidance 💬, Neurotrophin signaling pathway 💬, Pathogenic Escherichia coli infection 💬, Pathways in cancer 💬, MicroRNAs in cancer 💬, Chemical carcinogenesis - reactive oxygen species 💬, Chronic myeloid leukemia 💬, Viral myocarditis 💬 | D03658
D03658
|
Dasatinib
| 2件: 51 51, 85 |
45 |
ABL1
| 11件: ErbB signaling pathway ErbB signaling pathway 💬, Ras signaling pathway 💬, Cell cycle 💬, Axon guidance 💬, Neurotrophin signaling pathway 💬, Pathogenic Escherichia coli infection 💬, Pathways in cancer 💬, MicroRNAs in cancer 💬, Chemical carcinogenesis - reactive oxygen species 💬, Chronic myeloid leukemia 💬, Viral myocarditis 💬 | D06414
D06414
|
Dasatinib
| 2件: 51 51, 85 |
46 |
ABL1
| 11件: ErbB signaling pathway ErbB signaling pathway 💬, Ras signaling pathway 💬, Cell cycle 💬, Axon guidance 💬, Neurotrophin signaling pathway 💬, Pathogenic Escherichia coli infection 💬, Pathways in cancer 💬, MicroRNAs in cancer 💬, Chemical carcinogenesis - reactive oxygen species 💬, Chronic myeloid leukemia 💬, Viral myocarditis 💬 | D08066
D08066
|
Imatinib
| 12件: 13 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 |
47 |
ABL1
| 11件: ErbB signaling pathway ErbB signaling pathway 💬, Ras signaling pathway 💬, Cell cycle 💬, Axon guidance 💬, Neurotrophin signaling pathway 💬, Pathogenic Escherichia coli infection 💬, Pathways in cancer 💬, MicroRNAs in cancer 💬, Chemical carcinogenesis - reactive oxygen species 💬, Chronic myeloid leukemia 💬, Viral myocarditis 💬 | D08953
D08953
|
Nilotinib
| 5件: 6 6, 8, 34, 51, 86 |
48 |
GNRHR
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, GnRH signaling pathway 💬 | D00989
D00989
|
Leuprolide
| 5件: 1 1, 2, 3, 51, 76 |
49 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D00407
D00407
|
Methylprednisolone
| 28件: 51 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 |
50 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D00472
D00472
|
Prednisolone
| 26件: 51 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307 |
51 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D00473
D00473
|
Prednisone
| 31件: 51 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 127, 162, 164, 205, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 |
52 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D00751
D00751
|
Methylprednisolone
| 28件: 51 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 |
53 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D00979
D00979
|
Methylprednisolone
| 28件: 51 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 |
54 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D00980
D00980
|
Prednisolone
| 26件: 51 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307 |
55 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D00981
D00981
|
Prednisolone
| 26件: 51 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307 |
56 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D00982
D00982
|
Prednisolone
| 26件: 51 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307 |
57 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D01239
D01239
|
Prednisolone
| 26件: 51 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307 |
58 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D01998
D01998
|
Prednisolone
| 26件: 51 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307 |
59 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D02156
D02156
|
Prednisolone
| 26件: 51 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307 |
60 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D03301
D03301
|
Prednisolone
| 26件: 51 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307 |
61 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D05000
D05000
|
Methylprednisolone
| 28件: 51 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 |
62 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D05000
D05000
|
Methylprednisolone hemisuccinate
| 4件: 51 51, 53, 97, 211 |
63 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D05001
D05001
|
Methylprednisolone
| 28件: 51 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 |
64 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D05002
D05002
|
Methylprednisolone
| 28件: 51 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 |
65 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D07715
D07715
|
Clobetasol
| 2件: 51 51, 162 |
66 |
GUCY1A2
| 11件: Purine metabolism Purine metabolism 💬, Metabolic pathways 💬, cGMP-PKG signaling pathway 💬, Vascular smooth muscle contraction 💬, Gap junction 💬, Platelet activation 💬, Circadian entrainment 💬, Long-term depression 💬, Oxytocin signaling pathway 💬, Renin secretion 💬, Salivary secretion 💬 | D09572
D09572
|
Riociguat
| 6件: 51 51, 84, 86, 88, 225, 299 |
67 |
GUCY1A1
| 11件: Purine metabolism Purine metabolism 💬, Metabolic pathways 💬, cGMP-PKG signaling pathway 💬, Vascular smooth muscle contraction 💬, Gap junction 💬, Platelet activation 💬, Circadian entrainment 💬, Long-term depression 💬, Oxytocin signaling pathway 💬, Renin secretion 💬, Salivary secretion 💬 | D09572
D09572
|
Riociguat
| 6件: 51 51, 84, 86, 88, 225, 299 |
68 |
GUCY1B1
| 11件: Purine metabolism Purine metabolism 💬, Metabolic pathways 💬, cGMP-PKG signaling pathway 💬, Vascular smooth muscle contraction 💬, Gap junction 💬, Platelet activation 💬, Circadian entrainment 💬, Long-term depression 💬, Oxytocin signaling pathway 💬, Renin secretion 💬, Salivary secretion 💬 | D09572
D09572
|
Riociguat
| 6件: 51 51, 84, 86, 88, 225, 299 |
69 |
SERPIND1
| 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | D08547
D08547
|
Sulodexide
| 3件: 51 51, 271, 288 |
70 |
HMGCR
| 4件: Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis 💬, Metabolic pathways 💬, AMPK signaling pathway 💬, Bile secretion 💬 | D00434
D00434
|
Simvastatin
| 21件: 6 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 |
71 |
HMGCR
| 4件: Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis 💬, Metabolic pathways 💬, AMPK signaling pathway 💬, Bile secretion 💬 | D00887
D00887
|
Atorvastatin
| 18件: 13 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 299 |
72 |
HMGCR
| 4件: Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis 💬, Metabolic pathways 💬, AMPK signaling pathway 💬, Bile secretion 💬 | D01915
D01915
|
Rosuvastatin
| 11件: 6 6, 18, 46, 49, 51, 56, 79, 96, 97, 271, 299 |
73 |
HMGCR
| 4件: Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis 💬, Metabolic pathways 💬, AMPK signaling pathway 💬, Bile secretion 💬 | D07474
D07474
|
Atorvastatin
| 18件: 13 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 299 |
74 |
HMGCR
| 4件: Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis 💬, Metabolic pathways 💬, AMPK signaling pathway 💬, Bile secretion 💬 | D08492
D08492
|
Rosuvastatin
| 11件: 6 6, 18, 46, 49, 51, 56, 79, 96, 97, 271, 299 |
75 |
HRH1
| 3件: Calcium signaling pathway Calcium signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Inflammatory mediator regulation of TRP channels 💬 | D00300
D00300
|
Diphenhydramine
| 10件: 11 11, 13, 49, 51, 70, 86, 96, 222, 256, 300 |
76 |
HRH1
| 3件: Calcium signaling pathway Calcium signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Inflammatory mediator regulation of TRP channels 💬 | D00669
D00669
|
Diphenhydramine
| 10件: 11 11, 13, 49, 51, 70, 86, 96, 222, 256, 300 |
77 |
HRH1
| 3件: Calcium signaling pathway Calcium signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Inflammatory mediator regulation of TRP channels 💬 | D02419
D02419
|
Diphenhydramine
| 10件: 11 11, 13, 49, 51, 70, 86, 96, 222, 256, 300 |
78 |
HRH1
| 3件: Calcium signaling pathway Calcium signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Inflammatory mediator regulation of TRP channels 💬 | D03285
D03285
|
Diphenhydramine
| 10件: 11 11, 13, 49, 51, 70, 86, 96, 222, 256, 300 |
79 |
HRH1
| 3件: Calcium signaling pathway Calcium signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Inflammatory mediator regulation of TRP channels 💬 | D03360
D03360
|
Diphenhydramine
| 10件: 11 11, 13, 49, 51, 70, 86, 96, 222, 256, 300 |
80 |
HRH1
| 3件: Calcium signaling pathway Calcium signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Inflammatory mediator regulation of TRP channels 💬 | D03854
D03854
|
Diphenhydramine
| 10件: 11 11, 13, 49, 51, 70, 86, 96, 222, 256, 300 |
81 |
HTR1A
| 4件: cAMP signaling pathway cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Serotonergic synapse 💬, Taste transduction 💬 | D00702
D00702
|
Buspirone
| 3件: 6 6, 51, 179 |
82 |
HTR1A
| 4件: cAMP signaling pathway cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Serotonergic synapse 💬, Taste transduction 💬 | D07593
D07593
|
Buspirone
| 3件: 6 6, 51, 179 |
83 |
HTR4
| 4件: Calcium signaling pathway Calcium signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Serotonergic synapse 💬 | D09205
D09205
|
Prucalopride
| 3件: 13 13, 51, 96 |
84 |
TUBB8
| 10件: Phagosome Phagosome 💬, Gap junction 💬, Alzheimer disease 💬, Parkinson disease 💬, Amyotrophic lateral sclerosis 💬, Huntington disease 💬, Prion disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Pathogenic Escherichia coli infection 💬, Salmonella infection 💬 | D09587
D09587
|
Brentuximab vedotin
| 2件: 49 49, 51 |
85 |
TUBB2B
| 10件: Phagosome Phagosome 💬, Gap junction 💬, Alzheimer disease 💬, Parkinson disease 💬, Amyotrophic lateral sclerosis 💬, Huntington disease 💬, Prion disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Pathogenic Escherichia coli infection 💬, Salmonella infection 💬 | D09587
D09587
|
Brentuximab vedotin
| 2件: 49 49, 51 |
86 |
IGF1R
| 29件: EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance 💬, Endocrine resistance 💬, MAPK signaling pathway 💬, Ras signaling pathway 💬, Rap1 signaling pathway 💬, HIF-1 signaling pathway 💬, FoxO signaling pathway 💬, Oocyte meiosis 💬, Autophagy - animal 💬, Endocytosis 💬, mTOR signaling pathway 💬, PI3K-Akt signaling pathway 💬, AMPK signaling pathway 💬, Longevity regulating pathway 💬, Longevity regulating pathway - multiple species 💬, Focal adhesion 💬, Adherens junction 💬, Signaling pathways regulating pluripotency of stem cells 💬, Long-term depression 💬, Ovarian steroidogenesis 💬, Progesterone-mediated oocyte maturation 💬, Pathways in cancer 💬, Transcriptional misregulation in cancer 💬, Proteoglycans in cancer 💬, Glioma 💬, Prostate cancer 💬, Melanoma 💬, Breast cancer 💬, Hepatocellular carcinoma 💬 | D09680
D09680
|
Teprotumumab
| 1件: 51 51 |
87 |
IL1A
| 21件: MAPK signaling pathway MAPK signaling pathway 💬, Cytokine-cytokine receptor interaction 💬, Necroptosis 💬, Cellular senescence 💬, Osteoclast differentiation 💬, Hematopoietic cell lineage 💬, Non-alcoholic fatty liver disease 💬, AGE-RAGE signaling pathway in diabetic complications 💬, Type I diabetes mellitus 💬, Alzheimer disease 💬, Prion disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Pertussis 💬, Leishmaniasis 💬, Tuberculosis 💬, Measles 💬, Influenza A 💬, Inflammatory bowel disease 💬, Rheumatoid arthritis 💬, Graft-versus-host disease 💬, Fluid shear stress and atherosclerosis 💬 | D01583
D01583
|
Pirfenidone
| 11件: 13 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
88 |
IL1A
| 21件: MAPK signaling pathway MAPK signaling pathway 💬, Cytokine-cytokine receptor interaction 💬, Necroptosis 💬, Cellular senescence 💬, Osteoclast differentiation 💬, Hematopoietic cell lineage 💬, Non-alcoholic fatty liver disease 💬, AGE-RAGE signaling pathway in diabetic complications 💬, Type I diabetes mellitus 💬, Alzheimer disease 💬, Prion disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Pertussis 💬, Leishmaniasis 💬, Tuberculosis 💬, Measles 💬, Influenza A 💬, Inflammatory bowel disease 💬, Rheumatoid arthritis 💬, Graft-versus-host disease 💬, Fluid shear stress and atherosclerosis 💬 | D06635
D06635
|
Rilonacept
| 4件: 51 51, 106, 107, 266 |
89 |
IL1A
| 21件: MAPK signaling pathway MAPK signaling pathway 💬, Cytokine-cytokine receptor interaction 💬, Necroptosis 💬, Cellular senescence 💬, Osteoclast differentiation 💬, Hematopoietic cell lineage 💬, Non-alcoholic fatty liver disease 💬, AGE-RAGE signaling pathway in diabetic complications 💬, Type I diabetes mellitus 💬, Alzheimer disease 💬, Prion disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Pertussis 💬, Leishmaniasis 💬, Tuberculosis 💬, Measles 💬, Influenza A 💬, Inflammatory bowel disease 💬, Rheumatoid arthritis 💬, Graft-versus-host disease 💬, Fluid shear stress and atherosclerosis 💬 | D11253
D11253
|
Bermekimab
| 1件: 51 51 |
90 |
IL1B
| 44件: Antifolate resistance Antifolate resistance 💬, MAPK signaling pathway 💬, Cytokine-cytokine receptor interaction 💬, NF-kappa B signaling pathway 💬, Necroptosis 💬, Osteoclast differentiation 💬, Toll-like receptor signaling pathway 💬, NOD-like receptor signaling pathway 💬, Cytosolic DNA-sensing pathway 💬, C-type lectin receptor signaling pathway 💬, Hematopoietic cell lineage 💬, IL-17 signaling pathway 💬, Th17 cell differentiation 💬, TNF signaling pathway 💬, Inflammatory mediator regulation of TRP channels 💬, Non-alcoholic fatty liver disease 💬, AGE-RAGE signaling pathway in diabetic complications 💬, Alcoholic liver disease 💬, Type I diabetes mellitus 💬, Alzheimer disease 💬, Prion disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Pathogenic Escherichia coli infection 💬, Shigellosis 💬, Salmonella infection 💬, Pertussis 💬, Legionellosis 💬, Yersinia infection 💬, Leishmaniasis 💬, Chagas disease 💬, African trypanosomiasis 💬, Malaria 💬, Amoebiasis 💬, Tuberculosis 💬, Measles 💬, Human cytomegalovirus infection 💬, Influenza A 💬, Herpes simplex virus 1 infection 💬, Coronavirus disease - COVID-19 💬, Inflammatory bowel disease 💬, Rheumatoid arthritis 💬, Graft-versus-host disease 💬, Lipid and atherosclerosis 💬, Fluid shear stress and atherosclerosis 💬 | D01583
D01583
|
Pirfenidone
| 11件: 13 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
91 |
IL1B
| 44件: Antifolate resistance Antifolate resistance 💬, MAPK signaling pathway 💬, Cytokine-cytokine receptor interaction 💬, NF-kappa B signaling pathway 💬, Necroptosis 💬, Osteoclast differentiation 💬, Toll-like receptor signaling pathway 💬, NOD-like receptor signaling pathway 💬, Cytosolic DNA-sensing pathway 💬, C-type lectin receptor signaling pathway 💬, Hematopoietic cell lineage 💬, IL-17 signaling pathway 💬, Th17 cell differentiation 💬, TNF signaling pathway 💬, Inflammatory mediator regulation of TRP channels 💬, Non-alcoholic fatty liver disease 💬, AGE-RAGE signaling pathway in diabetic complications 💬, Alcoholic liver disease 💬, Type I diabetes mellitus 💬, Alzheimer disease 💬, Prion disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Pathogenic Escherichia coli infection 💬, Shigellosis 💬, Salmonella infection 💬, Pertussis 💬, Legionellosis 💬, Yersinia infection 💬, Leishmaniasis 💬, Chagas disease 💬, African trypanosomiasis 💬, Malaria 💬, Amoebiasis 💬, Tuberculosis 💬, Measles 💬, Human cytomegalovirus infection 💬, Influenza A 💬, Herpes simplex virus 1 infection 💬, Coronavirus disease - COVID-19 💬, Inflammatory bowel disease 💬, Rheumatoid arthritis 💬, Graft-versus-host disease 💬, Lipid and atherosclerosis 💬, Fluid shear stress and atherosclerosis 💬 | D06635
D06635
|
Rilonacept
| 4件: 51 51, 106, 107, 266 |
92 |
IL4R
| 8件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬, PI3K-Akt signaling pathway 💬, JAK-STAT signaling pathway 💬, Hematopoietic cell lineage 💬, Th1 and Th2 cell differentiation 💬, Th17 cell differentiation 💬, Pathways in cancer 💬, Inflammatory bowel disease 💬 | D10354
D10354
|
Dupilumab
| 4件: 51 51, 98, 160, 162 |
93 |
IL6
| 51件: EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance 💬, Antifolate resistance 💬, Cytokine-cytokine receptor interaction 💬, Viral protein interaction with cytokine and cytokine receptor 💬, HIF-1 signaling pathway 💬, FoxO signaling pathway 💬, PI3K-Akt signaling pathway 💬, Cellular senescence 💬, Toll-like receptor signaling pathway 💬, NOD-like receptor signaling pathway 💬, Cytosolic DNA-sensing pathway 💬, C-type lectin receptor signaling pathway 💬, JAK-STAT signaling pathway 💬, Hematopoietic cell lineage 💬, IL-17 signaling pathway 💬, Th17 cell differentiation 💬, TNF signaling pathway 💬, Intestinal immune network for IgA production 💬, Insulin resistance 💬, Non-alcoholic fatty liver disease 💬, AGE-RAGE signaling pathway in diabetic complications 💬, Alcoholic liver disease 💬, Alzheimer disease 💬, Prion disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Pathogenic Escherichia coli infection 💬, Salmonella infection 💬, Pertussis 💬, Legionellosis 💬, Yersinia infection 💬, Chagas disease 💬, African trypanosomiasis 💬, Malaria 💬, Amoebiasis 💬, Tuberculosis 💬, Hepatitis B 💬, Measles 💬, Human cytomegalovirus infection 💬, Influenza A 💬, Human T-cell leukemia virus 1 infection 💬, Kaposi sarcoma-associated herpesvirus infection 💬, |